Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.185 USD | +0.48% | -19.74% | -41.41% |
May. 10 | Palisade Bio, Inc. announced that it has received $3.999943 million in funding | CI |
May. 07 | Palisade Bio, Inc. Appoints Margery Fischbein to Its Board of Directors | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.41% | 4.84M | |
+65.27% | 62.59B | |
-1.27% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.51% | 26.21B | |
-21.77% | 19.09B | |
+5.05% | 13.08B | |
+25.50% | 12.26B | |
+28.61% | 12.05B |
- Stock Market
- Equities
- SNCA Stock
- News Palisade Bio, Inc.
- Palisade Bio Secures US FDA's Fast Track Designation for Investigational Drug LB1148